Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Azathioprine may be an effective treatment for severe hair loss.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Baricitinib helps patients with severe alopecia areata regrow hair.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Topical cyclosporin-A is recommended for severe alopecia areata.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Co-trimoxazole may help treat autoimmune diseases.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Topical tacrolimus is effective and safe for treating alopecia areata.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.